The lack of positivity for antibodies in the triple-SN-MG subgroup may reflect the low prevalence of LRP4 patients in the Brazilian population, the low sensitivity of the laboratory assays used, or also a portion of patients with antigens not yet described or non-antibody mechanisms. Here, LRP4 is linked to myasthenia gravis.